3 unknown, 2 not yet recruiting, 1 recruiting. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Unknown 3, Not yet recruiting 2, Recruiting 1 |
Follow Radiation: new trials by email Literature Review of Radiation trials Research Report on Radiation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Prophylactic Versus Late Salvage Recombinant Human Endostatin in Managing Radiosurgery-Induced Brain Injury for NSCLC Brain Metastases Recombinant Human Endostatin (Endostar) - Lung Cancer (Non-Small Cell), Radiation | Phase 2 | Not yet recruiting | Jiangmen Central Hospital | 49 | 2026-09-01 | 2026-10-01 |
| GCC 2545- Improving Post-Radiotherapy Respiratory Function Through Sparing Serial and Parallel Components in the Lung SOC Radiation Treatment Planning, INSPIRE Radiation Treatment Planning - Lung Cancer (NSCLC), Radiation | Phase 2 | Not yet recruiting | University of Maryland, Baltimore | 70 | 2026-08-01 | 2026-07-01 |
| SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer radiotherapy, Ivonescimab (20mg/kg Q3W), Non-operative Management - Rectal Cancer, Radiation | Phase 2 | Recruiting | Zhejiang Cancer Hospital | 30 | 2025-10-27 | 2026-08-07 |
| A Multicenter Phase II Trial of Post-operative Concurrent Chemoradiotherapy Using Weekly Cisplatin With Tislelizumab for Patients With High-risk Head and Neck Squamous Cell Carcinomaļ¼The POTENTIAL Study Tislelizumab - Head and Neck Cancer, Radiation | Phase 2 | Unknown | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 38 | 2021-04-01 | 2021-03-24 |
| Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer FOLFOXIRI, Short-Course Radiation Therapy(5Gy*5), XELOX - Rectal Neoplasms, Drug Therapy | Phase 2 | Unknown | China Medical University, China | 30 | 2018-04-01 | 2021-04-14 |
| Intensity-modulated Radiotherapy Protocol in Cervix Cancer High-dose Intensity-modulated radiotherapy - Radiation | Phase 2 | Unknown | Seoul St. Mary's Hospital | 80 | 2015-01-01 | 2016-12-15 |
Carcinoma, Non-Small-Cell Lung (2) · Rectal Neoplasms (2) · Brain Edema (1) · Brain Injuries (1) · Head and Neck Neoplasms (1) · Lung Neoplasms (1)
Neoplasms (5) · Neoplasms by Site (5) · Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Colorectal Neoplasms (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Intestinal Diseases (2) · Intestinal Neoplasms (2) · Lung Diseases (2) · Rectal Diseases (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2)
Capecitabine (1) · Endostatins (1) · FOLFOXIRI protocol (1) · Fluorouracil (1) · Irinotecan (1) · Oxaliplatin (1) · Radiotherapy (1) · Radiotherapy, Intensity-Modulated (1) · Surgical Procedures, Operative (1) · XELOX (1) · endostar protein (1) · tislelizumab (1)
China Medical University, China (1) · Jiangmen Central Hospital (1) · Seoul St. Mary's Hospital (1) · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1) · University of Maryland, Baltimore (1) · Zhejiang Cancer Hospital (1)
China (2) · South Korea (1) · United States (1)
Amit Sawant, PhD (1) · Jingdong Zhang (1) · Jong Hoon Lee, MD (1)